China BioPharma Corp (fka CHBO)

[MakeMoneyMan]

Looking at the Ludlow report they state with 10-13 mil of sales and p/s of 3 and only 90 million shares outstanding, the target would be .30 to .40
Don, how do you come up with .75 if you project twice the shares and half the revenue.
It would seem that the target would be more like .07 to .10 in this situaton (with twice the shares and half the revenue).



PRINCETON, N.J., June 18 /PRNewswire-FirstCall/ -- Ludlow China upgrades China Biopharma, Inc. (OTC Bulletin Board: CBPC - News) from a C to B- rating based on a recent guidance for fiscal year 2007 issued by the company. On June 13, 2007, the company issued revenue guidance for fiscal year 2007 of between $10 million to $13 million, with projected positive net income. Based on a price to sales (P/S) ratio of just 3 times sales that would give CBPC a valuation of $30 to $39 million. With around 90 million shares outstanding, that would give CBPC a potential target of around $0.30 to $0.40 a share